BioSig Technologies, Inc. (BSGM): Price and Financial Metrics

BioSig Technologies, Inc. (BSGM): $0.71

0.02 (+2.78%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

BSGM Price/Volume Stats

Current price $0.71 52-week high $16.50
Prev. close $0.69 52-week low $0.26
Day low $0.61 Volume 289,300
Day high $0.73 Avg. volume 446,423
50-day MA $2.27 Dividend yield N/A
200-day MA $6.16 Market Cap 6.33M

BSGM Stock Price Chart Interactive Chart >

BSGM POWR Grades

  • Sentiment is the dimension where BSGM ranks best; there it ranks ahead of 57.58% of US stocks.
  • BSGM's strongest trending metric is Stability; it's been moving down over the last 122 days.
  • BSGM ranks lowest in Value; there it ranks in the 2nd percentile.

BSGM Stock Summary

  • For BSGM, its debt to operating expenses ratio is greater than that reported by just 6.16% of US equities we're observing.
  • With a price/sales ratio of 273.7, BIOSIG TECHNOLOGIES INC has a higher such ratio than 98.68% of stocks in our set.
  • In terms of volatility of its share price, BSGM is more volatile than 93.5% of stocks we're observing.
  • Stocks that are quantitatively similar to BSGM, based on their financial statements, market capitalization, and price volatility, are TNON, EXFY, HIPO, BLBX, and DKNG.
  • Visit BSGM's SEC page to see the company's official filings. To visit the company's web site, go to www.biosig.com.

BSGM Valuation Summary

  • BSGM's price/earnings ratio is -1.4; this is 104.8% lower than that of the median Healthcare stock.
  • Over the past 112 months, BSGM's price/earnings ratio has gone up 2.1.

Below are key valuation metrics over time for BSGM.

Stock Date P/S P/B P/E EV/EBIT
BSGM 2023-12-29 297.2 -36.1 -1.4 -1.4
BSGM 2023-12-28 296.5 -36.0 -1.4 -1.4
BSGM 2023-12-27 305.0 -37.1 -1.4 -1.4
BSGM 2023-12-26 297.9 -36.2 -1.4 -1.4
BSGM 2023-12-22 298.6 -36.3 -1.4 -1.4
BSGM 2023-12-21 256.0 -31.1 -1.2 -1.2

BSGM Growth Metrics

    The 5 year net income to common stockholders growth rate now stands at -234.32%.
  • Its year over year price growth rate is now at -66.16%.
  • Its 5 year net cashflow from operations growth rate is now at -222.59%.
BSGM's revenue has moved up $159,000 over the prior 55 months.

The table below shows BSGM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0.159 -23.322 -28.872
2022-06-30 0.132 -25.133 -29.736
2022-03-31 0.331 -25.349 -31.57
2021-12-31 0.441 -26.399 -31.926
2021-09-30 0.433 -26.77224 -33.5746
2021-06-30 0.325 -26.28766 -37.72384

BSGM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BSGM has a Quality Grade of F, ranking ahead of 2.09% of graded US stocks.
  • BSGM's asset turnover comes in at 0.012 -- ranking 168th of 186 Medical Equipment stocks.
  • IDXG, CERS, and NVCR are the stocks whose asset turnover ratios are most correlated with BSGM.

The table below shows BSGM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.012 0.505 -124.410
2021-03-31 0.004 0.161 -37.903
2020-12-31 0.000 NA -21.740
2020-09-30 0.000 NA -22.716
2020-06-30 0.000 NA -20.310
2020-03-31 0.000 NA -17.440

BSGM Price Target

For more insight on analysts targets of BSGM, see our BSGM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.00 Average Broker Recommendation 1.5 (Moderate Buy)

BioSig Technologies, Inc. (BSGM) Company Bio


BioSig Technologies, Inc., a medical device company, engages in developing and commercializing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. The company's proprietary product include precise uninterrupted real-time evaluation of electrograms electrophysiology system, a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures in an electrophysiology laboratory under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.


BSGM Latest News Stream


Event/Time News Detail
Loading, please wait...

BSGM Latest Social Stream


Loading social stream, please wait...

View Full BSGM Social Stream

Latest BSGM News From Around the Web

Below are the latest news stories about BIOSIG TECHNOLOGIES INC that investors may wish to consider to help them evaluate BSGM as an investment opportunity.

Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why

Key Insights BioSig Technologies to hold its Annual General Meeting on 18th of December CEO Ken Londoner's total...

Yahoo | December 12, 2023

BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024

Westport, CT, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today issued its 2023 letter to shareholders to recap recent achievements and offer insights about the year ahead. In the letter, Kenneth Londoner, Chairman & CEO of BioSig, states “BioSig’s capacity for innovation is stronger than ever, and to our knowledge, our opp

Yahoo | December 6, 2023

BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 6,996,922 shares of its common stock, Series A warrants to purchase up to 6,996,922 shares of common stock and Series B warrants

Yahoo | November 13, 2023

BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP

32-year career in medical device and electrophysiology business expansion for industry bellwethers; led multiple company exits including a $1B sale in 2018 Part of leadership team that grew Johnson & Johnson’s original cardiology/electrophysiology business from $22M to $500M in 7 yearsWestport, CT, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Westport, CT, November 7, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to del

Yahoo | November 7, 2023

BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care

PURE EP™ subscriber community now includes two of top three U.S. health systems in cardiology: Mayo Clinic-Phoenix and Cleveland ClinicWestport, CT, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, announced today that Mayo Clinic-Phoenix—an existing user of the PURE EP™ Platform—has upgraded to the Platform’s subsc

Yahoo | November 2, 2023

Read More 'BSGM' Stories Here

BSGM Price Returns

1-mo -47.01%
3-mo -76.74%
6-mo -87.61%
1-year -93.83%
3-year -98.31%
5-year -98.69%
YTD -85.05%
2023 13.10%
2022 -81.17%
2021 -42.82%
2020 -34.12%
2019 38.64%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!